P1303: DARATUMUMAB-BASED MAINTENANCE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA AFTER SALVAGE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION

• Oren Pasvolsky,
• Krina K. Patel,
• Qaiser Bashir,
• Mikael Rauf,
• Dawen Sui,
• Samer Srour,
• Mark R. Tanner,
• Uday R. Popat,
• Neeraj Saini,
• Chitra Hosing,
• Jeremy L. Ramdial,
• Elisabet Manasanch,
• Hans C. Lee,
• Gregory Kaufman,
• Sheeba K. Thomas,
• Donna M. Weber,
• Melody Becnel,
• Guilin Tang,
• Robert Z. Orlowski,
• Dipa Patel,
• Richard E. Champlin,
• Yago Nieto,
• Elizabeth J. Shpall,
• Muzaffar H. Qazilbash

Affiliations

Oren Pasvolsky

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

Krina K. Patel

4 The University of Texas MD Anderson Cancer Center, Department of Lymphoma & Myeloma, Houston, United States

Qaiser Bashir

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

Mikael Rauf

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

Dawen Sui

5 The University of Texas MD Anderson Cancer Center, Department of Biostatistics, Houston, United States

Samer Srour

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

Mark R. Tanner

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

Uday R. Popat

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

Neeraj Saini

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

Chitra Hosing

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

Jeremy L. Ramdial

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

Elisabet Manasanch

4 The University of Texas MD Anderson Cancer Center, Department of Lymphoma & Myeloma, Houston, United States

Hans C. Lee

4 The University of Texas MD Anderson Cancer Center, Department of Lymphoma & Myeloma, Houston, United States

Gregory Kaufman

4 The University of Texas MD Anderson Cancer Center, Department of Lymphoma & Myeloma, Houston, United States

Sheeba K. Thomas

4 The University of Texas MD Anderson Cancer Center, Department of Lymphoma & Myeloma, Houston, United States

Donna M. Weber

4 The University of Texas MD Anderson Cancer Center, Department of Lymphoma & Myeloma, Houston, United States

Melody Becnel

4 The University of Texas MD Anderson Cancer Center, Department of Lymphoma & Myeloma, Houston, United States

Guilin Tang

6 The University of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, United States

Robert Z. Orlowski

4 The University of Texas MD Anderson Cancer Center, Department of Lymphoma & Myeloma, Houston, United States

Dipa Patel

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

Richard E. Champlin

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

Yago Nieto

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

Elizabeth J. Shpall

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

Muzaffar H. Qazilbash

1 The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States